IL242939B
Ultra-pure agonists of guanylate cyclase c, method of making and using same
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
48 members in 18 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 201361831402 | United States of America | P | |
| 2014041143 | United States of America | W |
Members48
| Document | Office | Kind | |
|---|---|---|---|
| CA2913737A1 | Canada | A1 | |
| WO2014197720A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2014197720A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2014274812A1 | Australia | A1 | |
| KR20160039577A | Republic of Korea | A | |
| EP3004138A2 | European Patent Office (EPO) | A2 | |
| US2016145307A1 | United States of America | A1 | |
| EA201592263A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CN105764916A | China | A | |
| JP2016522216A | Japan | A | |
| HK1221959A | Hong Kong, China | A | |
| HK1221959A1 | Hong Kong, China | A1 | |
| BR112015030326A2 | Brazil | A2 | |
| US10011637B2 | United States of America | B2 | |
| AU2014274812B2 | Australia | B2 | |
| AU2018226473A1 | Australia | A1 | |
| US2019002501A1 | United States of America | A1 | |
| IL242939A | Israel | A | |
| IL242939BThis record | Israel | B | |
| JP6606491B2 | Japan | B2 | |
| AU2018226473B2 | Australia | B2 | |
| AU2020205349A1 | Australia | A1 | |
| US10745441B2 | United States of America | B2 | |
| US2020399315A1 | United States of America | A1 | |
| CN105764916B | China | B | |
| KR102272746B1 | Republic of Korea | B1 | |
| CN113388007A | China | A | |
| US11142549B2 | United States of America | B2 | |
| AU2020205349B2 | Australia | B2 | |
| US2021403508A1 | United States of America | A1 | |
| US2022119449A1 | United States of America | A1 | |
| US11319346B2 | United States of America | B2 | |
| US2023340023A1 | United States of America | A1 | |
| US11834521B2 | United States of America | B2 | |
| EP3004138B1 | European Patent Office (EPO) | B1 | |
| PT3004138T | Portugal | T | |
| PL3004138T3 | Poland | T3 | |
| RS65632B1 | Serbia | B1 | |
| RS65632B1 | Serbia | B1 | |
| SI3004138T1 | Slovenia | T1 | |
| US2024287137A1 | United States of America | A1 | |
| EP4424697A2 | European Patent Office (EPO) | A2 | |
| HRP20240805T1 | Croatia | T1 | |
| ES2981866T3 | Spain | T3 | |
| US12146003B2 | United States of America | B2 | |
| EP4424697A3 | European Patent Office (EPO) | A3 | |
| CA2913737C | Canada | C | |
| US2025171497A1 | United States of America | A1 |
3 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication
- 242939
- Application
- 242939
Titles2
- English
- Ultra-pure agonists of guanylate cyclase c, method of making and using same
- Hebrew
- אגוניסטים של גואנילט ציקלז c בדרגת זקוק גבוה, שיטות לייצורם ושימושים בהם
Classification
- CPC, 6
- C07K7/08
- C12N9/88
- C12Y406/01002
- B01D15/424
- C07K1/14
- A61K38/10